Valuation: Neogen Corporation

Market Cap 2.56B 2.29B 2.13B 1.93B 3.64B 243B 3.67B 25.54B 10B 126B 9.62B 9.41B 406B P/E 2027 *
-76.5x
P/E 2028 * -107x
Enterprise Value 2.56B 2.29B 2.13B 1.93B 3.64B 243B 3.67B 25.54B 10B 126B 9.62B 9.41B 406B EV / Sales 2027 *
2.89x
EV / Sales 2028 * 2.93x
Free-Float
99.25%
Yield 2027 *
-
Yield 2028 * -

Last Transcript: Neogen Corporation

1 day-2.25%
1 week-1.92%
Current month-8.36%
1 month-0.42%
3 months+21.55%
6 months+28.34%
Current year+67.81%
1 week 11.13
Extreme 11.1337
12.21
1 month 11.13
Extreme 11.1337
14.26
Current year 6.89
Extreme 6.89
14.26
1 year 5.37
Extreme 5.37
14.26
3 years 3.87
Extreme 3.8701
20.89
5 years 3.87
Extreme 3.8701
47.8
10 years 3.87
Extreme 3.8701
48.85
Manager TitleAgeSince
Chief Executive Officer 50 2025-08-10
Director of Finance/CFO 56 2025-11-02
Compliance Officer 61 2026-04-07
Director TitleAgeSince
Director/Board Member 65 2013-12-31
Chairman 70 2020-04-09
Director/Board Member 58 2020-10-07
Date Insider Type Main position Quantity % Market Cap. Importance
10/9/26 Buy

Chief Executive Officer

505 0.0002%
10/1/26 Free

Director

30,362 0.0139%
10/1/26 Free

Director

30,362 0.0139%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-1.92%+97.14%-24.18% 2.62B
+0.78%+4.53%-21.90%+12.92% 176B
+1.17%+6.80%-2.69%+29.25% 118B
-0.02%+1.56%-22.57%+9.57% 108B
-0.31%-0.27%-46.72%-10.85% 75.34B
+1.55%+4.34%+4.14%+74.68% 62.03B
-0.08%+0.66%+19.28%+66.34% 52.8B
-0.80%+3.92%+0.38%-27.57% 51.45B
-0.69%+0.95%-17.84%+22.09% 41.28B
-0.17%+0.42% - - 31.37B
Average -0.08%+1.70%+1.02%+16.92% 71.91B
Weighted average by Cap. +0.36%+3.30%-13.57%+19.63%

Financials

2027 *2028 *
Net sales 887M 792M 738M 669M 1.26B 84.16B 1.27B 8.84B 3.46B 43.77B 3.33B 3.26B 140B 875M 781M 728M 660M 1.24B 83.01B 1.25B 8.72B 3.41B 43.17B 3.28B 3.21B 139B
Net income -33.93M -30.31M -28.25M -25.62M -48.21M -3.22B -48.59M -338M -132M -1.68B -127M -125M -5.38B -23.73M -21.2M -19.76M -17.92M -33.72M -2.25B -33.98M -237M -92.67M -1.17B -89.13M -87.18M -3.76B
Net Debt - -
Projected Income Statement - Annual - Neogen Corporation
Logo Neogen Corporation
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Employees
2,636
Date Price Change Volume
26-10-13 US$11.73 -2.25% 2,338,560
26-10-12 US$12.00 +1.27% 2,570,500
26-10-09 US$11.85 +1.20% 3,647,744
26-10-08 US$11.71 +0.26% 8,670,443
26-10-07 US$11.68 -2.34% 12,969,335
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Neogen Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
11.73USD
Average target price
14.00USD
Spread / Average Target
+19.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Neogen Corporation
  1. Stock Market
  2. Stocks
  3. NEOG Stock